More on INMD
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $14.81 |
|
|||
| Open | $14.68 | ||||
| 52 Wk High | $14.13 | ||||
| 52 Wk Low | $7.40 | ||||
| Day High | $14.81 | ||||
| Day Low | $14.37 | ||||
| P/E | 34.02 | ||||
| EPS | $0.43 | ||||
| Volume | 1,141,040 | ||||
- Doma Perpetual opposes InMode's $16.20-per-share CEO-led buyout
- DOMA PERPETUAL CAPITAL MANAGEMENT STRONGLY OPPOSES INMODE BUYOUT AS PROPOSED; PLANS TO VOTE AGAINST DEAL
- Form 6-K InMode Ltd. For: Jun 25
- The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
- Form SCHEDULE 13D/A InMode Ltd. Filed by: Mizrahy Moshe
- InMode receives $16.20-per-share buyout proposal from CEO-led group
- InMode Confirms Receipt of Unsolicited Proposal
- Form 6-K InMode Ltd. For: Jun 24
- Form 6-K InMode Ltd. For: Jun 18
- After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
Entities mentioned with INMD
- Earnings | View Related Stories »
- FDA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- Stock Buyback | View Related Stories »
- Needham & Company | View Related Stories »
- Show More...
